Mr David Fitzgerald

KANDO id: 5795

Bio

David has broad experience in both private equity and mergers & acquisitions. David's primary focus has been on the healthcare, information technology and business services sectors. Prior to joining Petra, David was a General Partner at Richland Ventures, a venture capital fund with $340 million in assets under management. Earlier in his career, David led market development and acquisition activities for InformDx, a diagnostic laboratory company and THG Management Services, a managed healthcare company. David has Board level experience with many successful growth companies including: US Healthworks, Televox (sold to West Corp.), Appriss (sold to Bain Capital), Synhrgy (sold to Mercer), Nuvox Communications (sold to Windstream). He currently serves as a director on the boards of SpecialtyCare, New Century Hospice, Superior Global Solutions and Salveo Specialty Pharmacy. David received a B.A. degree from Washington & Lee University.

Education